Wingstop Inc. Files 8-K with Corporate Details
Ticker: WING · Form: 8-K · Filed: Dec 9, 2024 · CIK: 1636222
| Field | Detail |
|---|---|
| Company | Wingstop Inc. (WING) |
| Form Type | 8-K |
| Filed Date | Dec 9, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $250 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K
TL;DR
Wingstop filed an 8-K on Dec 9th with corporate info. All good.
AI Summary
Wingstop Inc. filed an 8-K on December 9, 2024, reporting other events and financial statements. The filing details the company's principal executive offices located at 2801 N Central Expressway, Suite 1600, Dallas, Texas, 75204, with a business phone number of (972) 686-6500. The company was incorporated in Delaware and its fiscal year ends on December 28.
Why It Matters
This filing provides essential corporate information and updates for Wingstop Inc., which is important for investors and stakeholders to track the company's official details.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain any material non-public information that would significantly impact the company's stock price.
Key Players & Entities
- Wingstop Inc. (company) — Registrant
- December 9, 2024 (date) — Date of Report
- 2801 N Central Expressway Suite 1600 Dallas , Texas 75204 (address) — Principal executive offices
- 972-686-6500 (phone_number) — Registrant's telephone number
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Wingstop Inc.
On what date was this 8-K report filed?
The report was filed on December 9, 2024.
What is Wingstop Inc.'s principal executive office address?
The principal executive offices are located at 2801 N Central Expressway Suite 1600, Dallas, Texas, 75204.
What is the registrant's telephone number?
The registrant's telephone number is (972) 686-6500.
In which state was Wingstop Inc. incorporated?
Wingstop Inc. was incorporated in Delaware.
Filing Stats: 1,075 words · 4 min read · ~4 pages · Grade level 13.5 · Accepted 2024-12-09 08:05:33
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share WING NASDAQ Global Select Mar
- $250 million — Co. LLC ("Goldman Sachs") to repurchase $250 million of the Company's common stock, par valu
Filing Documents
- wing-20241209.htm (8-K) — 32KB
- 0001636222-24-000153.txt ( ) — 155KB
- wing-20241209.xsd (EX-101.SCH) — 2KB
- wing-20241209_lab.xml (EX-101.LAB) — 21KB
- wing-20241209_pre.xml (EX-101.PRE) — 12KB
- wing-20241209_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On December 9, 2024, Wingstop Inc. (the "Company") entered into an accelerated share repurchase agreement (the "ASR Agreement") with Goldman Sachs & Co. LLC ("Goldman Sachs") to repurchase $250 million of the Company's common stock, par value $0.01 per share ("Common Stock"). The Company is funding the repurchases under the ASR Agreement with existing cash and cash equivalents, including the proceeds from its recently completed financing transaction. The ASR Agreement is being executed under the Company's previously announced share repurchase program. Under the terms of the ASR Agreement, on December 9, 2024, the Company will make a $250 million payment to Goldman Sachs and will receive an initial delivery of approximately 551,325 shares of Common Stock. The final number of shares of Common Stock to be repurchased from Goldman Sachs will be based on the volume-weighted average share price of the Company's Common Stock during the term of the transaction, less a discount and subject to adjustments pursuant to the terms of the ASR Agreement. At settlement, Goldman Sachs may be required to deliver additional shares of Common Stock to the Company, or the Company may be required either to make a cash payment or deliver shares of Common Stock to Goldman Sachs, at the Company's election. The ASR Agreement contains customary terms for this type of transaction, including but not limited to the mechanisms to determine the number of shares of Common Stock or the amount of cash that will be delivered at settlement, the required timing of delivery of the Common Stock, provisions for adjustments to the transaction terms, the circumstances under which the ASR Agreement may be accelerated, extended or terminated, and various acknowledgments, representations and warranties made by the Company and Goldman Sachs to each other. The final settlement of the transactions under the ASR Agreement is expected to occur no later than the end of the fiscal first quar
Forward-looking Statements
Forward-looking Statements This Current Report on Form 8-K includes statements of our expectations, intentions, plans and beliefs that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to come within the safe harbor protection provided by those sections. These statements, which involve risks and uncertainties, relate to the discussion of our expectations concerning transactions under the ASR Agreement. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms "may," "will," "should," "expect," "intend," "plan," "outlook," "guidance," "anticipate," "believe," "think," "estimate," "seek," "predict," "can," "could," "project," "potential" or, in each case, their negative or other variations or comparable terminology, although not all forward-looking statements are accompanied by such terms. These forward-looking statements are made based on expectations and beliefs concerning future events affecting us and are subject to uncertainties, risks, and factors relating to our operations and business environments, all of which are difficult to predict and many of which are beyond our control, that could cause our actual results to differ materially from those matters expressed or implied by these forward-looking statements. Please refer to the risk factors discussed in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which can be found at the SEC's website www.sec.gov. The discussion of these risks is specifically incorporated by reference into this Current Report on Form 8-K. When considering forward-looking statements in this Current Report on Form 8-K or that we make in other reports or statements, you should keep in mind the cautionary statements in this Current Report on Form 8-K and future reports we file with the SEC. New risks and u
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document)
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Wingstop Inc. Date: December 9, 2024 By: /s/ Alex R. Kaleida Chief Financial Officer (Principal Financial and Accounting Officer)